Investors
Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain.
Shareholder Information
| Date | Title | Document |
|---|---|---|
| 22/05/23 | Notice of 2023 AGM | Download |
| 08/03/23 | FAQs and Transfer Form regarding proposed AIM cancellation | Download |
| 08/03/23 | Shareholder Circular and Notice of General Meeting to be held on 24 March 2023 | Download |
| 06/01/23 | Shareholder Circular and Notice of General Meeting to be held on 23 January 2023 | Download |
| 23/05/22 | Notice of 2022 AGM | Download |
| 21/05/21 | Notice of 2021 AGM | Download |
| 08/12/20 | Notice of 2020 AGM | Download |
| 12/02/20 | Shareholder Circular and Notice of General Meeting to be held on 2 March 20 | Download |
| 19/06/19 | Notice of 2019 AGM | Download |
| 05/02/19 | Shareholder Circular, Open Offer & Notice of General Meeting Panel Waiver | Download |
| 28/09/18 | Shareholder Circular and Notice of General Meeting to be held on 15 October 18 | Download |
| 13/08/18 | Notice of 2018 AGM | Download |
| 28/09/17 | Notice of General Meeting to be held on 16 October 2017 | Download |
| 11/04/17 | Notice of Annual General Meeting 2017 | Download |
| 12/10/16 | Notice of General Meeting to be held on 28 October 2016 | Download |
| 11/05/16 | Notice of 2016 AGM | Download |
| 21/05/15 | Notice of 2015 AGM | Download |
Share Detail
| Number of shares | 96,679,412 |
| Country of listing | US |
| Status | NASDAQ Listed |
| Index | NASDAQ |
| Tickers | NASDAQ:BDRX |
| CUSIP | 59564R609 |
The percentage of 2p Ordinary shares not being held in public hands is 0.07%
Shares held in treasury: Nil.
There are no restrictions on the transfer of Ordinary shares in the Company.
Information correct as of 11 May 2023.
ADR Information
| Ticker | Structure | Exchange | Ratio | DR ISIN | CUSIP |
|---|---|---|---|---|---|
| BDRX | Level III ADR | NASDAQ | 1 ADR : 5 Ordinary Shares | US59564R6099 | 59564R609 |